136 related articles for article (PubMed ID: 8055336)
1. Vasopressin V1 receptor in rat hippocampus is regulated by adrenocortical functions.
Saito R; Ishiharada N; Ban Y; Honda K; Takano Y; Kamiya H
Brain Res; 1994 May; 646(1):170-4. PubMed ID: 8055336
[TBL] [Abstract][Full Text] [Related]
2. Pituitary binding of vasopressin is altered by experimental manipulations of the hypothalamo-pituitary-adrenocortical axis in normal as well as homozygous (di/di) Brattleboro rats.
Antoni FA; Holmes MC; Kiss JZ
Endocrinology; 1985 Oct; 117(4):1293-9. PubMed ID: 3161722
[TBL] [Abstract][Full Text] [Related]
3. Corticosteroid regulation of gene expression and binding characteristics of vasopressin receptors in the rat brain.
Patchev VK; Almeida OF
Eur J Neurosci; 1995 Jul; 7(7):1579-83. PubMed ID: 7551184
[TBL] [Abstract][Full Text] [Related]
4. Effects of an orally active vasopressin V1 receptor antagonist.
Burrell LM; Phillips PA; Stephenson J; Risvanis J; Hutchins AM; Johnston CI
Clin Exp Pharmacol Physiol; 1993 May; 20(5):388-91. PubMed ID: 8391950
[TBL] [Abstract][Full Text] [Related]
5. Distinct mechanisms of action of V1 antagonists OPC-21268 and [d(CH2)5Tyr(Me)AVP] in mesangial cells.
Jamil KM; Watanabe T; Nakao A; Okuda T; Kurokawa K
Biochem Biophys Res Commun; 1993 Jun; 193(2):738-43. PubMed ID: 8390252
[TBL] [Abstract][Full Text] [Related]
6. Characterization of a novel non-peptide vasopressin V1 receptor antagonist (OPC-21268) in the rat.
Burrell LM; Phillips PA; Stephenson J; Risvanis J; Hutchins AM; Johnston CI
J Endocrinol; 1993 Aug; 138(2):259-66. PubMed ID: 8228734
[TBL] [Abstract][Full Text] [Related]
7. Arginin-vasopressin regulates proliferative activity of the regenerating rat adrenal cortex.
Trejter M; Carraro G; Rucinski M; Hochol A; Rebuffat P; Nussdorfer GG; Malendowicz LK
Int J Mol Med; 2005 Jun; 15(6):993-7. PubMed ID: 15870905
[TBL] [Abstract][Full Text] [Related]
8. Enhanced pressor response in spontaneously hypertensive rats induced by stimulation of vasopressin-V1 receptors.
Yamauchi T; Ogura T; Oishi T; Harada K; Hashimoto M; Mimura Y; Asano N; Ota Z; Kageyama J
Acta Med Okayama; 1995 Feb; 49(1):53-9. PubMed ID: 7762410
[TBL] [Abstract][Full Text] [Related]
9. Blocking effects of V1 (OPC-21268) and V2 (OPC-31260) antagonists on the negative inotropic response to vasopressin in isolated dog heart preparations.
Furukawa Y; Takayama S; Ren LM; Sawaki S; Inoue Y; Chiba S
J Pharmacol Exp Ther; 1992 Nov; 263(2):627-31. PubMed ID: 1331408
[TBL] [Abstract][Full Text] [Related]
10. Effect of a new V1 antagonist (OPC-21268) on vascular action of vasopressin in cultured rat vascular smooth muscle cells.
Okada K; Ishikawa S; Saito T
Biochem Biophys Res Commun; 1991 Jul; 178(2):707-12. PubMed ID: 1650196
[TBL] [Abstract][Full Text] [Related]
11. Vasopressin potentiates mineralocorticoid selectivity by stimulating 11 beta hydroxysteroid deshydrogenase in rat collecting duct.
Alfaidy N; Blot-Chabaud M; Bonvalet JP; Farman N
J Clin Invest; 1997 Nov; 100(10):2437-42. PubMed ID: 9366557
[TBL] [Abstract][Full Text] [Related]
12. Arginine vasopressin-induced natriuresis in the anaesthetized rat: involvement of V1 and V2 receptors.
Smith CP; Balment RJ
J Endocrinol; 1993 Feb; 136(2):283-8. PubMed ID: 8459193
[TBL] [Abstract][Full Text] [Related]
13. OPC-21268, an orally effective, nonpeptide vasopressin V1 receptor antagonist.
Yamamura Y; Ogawa H; Chihara T; Kondo K; Onogawa T; Nakamura S; Mori T; Tominaga M; Yabuuchi Y
Science; 1991 Apr; 252(5005):572-4. PubMed ID: 1850553
[TBL] [Abstract][Full Text] [Related]
14. Hepatic vasopressin receptor: differential effects of divalent cations, guanine nucleotides, and N-ethylmaleimide on agonist and antagonist interactions with the V1 subtype receptor.
Gopalakrishnan V; McNeill JR; Sulakhe PV; Triggle CR
Endocrinology; 1988 Aug; 123(2):922-31. PubMed ID: 2969327
[TBL] [Abstract][Full Text] [Related]
15. Effect of vasopressin V1- and V2-receptor stimulation on blood pressure in DOCA-salt hypertensive rats.
Mimura Y; Ogura T; Yamauchi T; Otsuka F; Oishi T; Harada K; Hashimoto M; Ota Z
Acta Med Okayama; 1995 Aug; 49(4):187-94. PubMed ID: 7502678
[TBL] [Abstract][Full Text] [Related]
16. Evidence for the existence of vasopressin V2 receptor mRNA in rat hippocampus.
Hirasawa A; Nakayama Y; Ishiharada N; Honda K; Saito R; Tsujimoto G; Takano Y; Kamiya H
Biochem Biophys Res Commun; 1994 Dec; 205(3):1702-6. PubMed ID: 7811254
[TBL] [Abstract][Full Text] [Related]
17. In vitro macro- and microautoradiographic localization of V1 and V2 receptors in the rat kidney using OPC-21268 and OPC-31260.
Mimura Y; Ogura T; Hayakawa N; Otsuka F; Hashimoto M; Yamauchi T; Makino H; Ogawa N
Nephron; 1997; 76(3):331-6. PubMed ID: 9226235
[TBL] [Abstract][Full Text] [Related]
18. Arginine vasopressin produces renal vasodilation via V2 receptors in conscious dogs.
Naitoh M; Suzuki H; Murakami M; Matsumoto A; Ichihara A; Nakamoto H; Yamamura Y; Saruta T
Am J Physiol; 1993 Oct; 265(4 Pt 2):R934-42. PubMed ID: 8238468
[TBL] [Abstract][Full Text] [Related]
19. Regulation of adrenocortical function by vasopressin.
Gallo-Payet N; Guillon G
Horm Metab Res; 1998; 30(6-7):360-7. PubMed ID: 9694564
[TBL] [Abstract][Full Text] [Related]
20. In-vitro and in-vivo studies of the effects of arginine-vasopressin on the secretion and growth of rat adrenal cortex.
Mazzochi G; Malendowicz LK; Meneghelli V; Gottardo G; Nussdorfer GG
Histol Histopathol; 1995 Apr; 10(2):359-70. PubMed ID: 7599433
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
